Cost-effective analysis of atorvastatin based on outcome data from a large cohort undergoing PCI before and after the availability of atorvastatin for patients with social health insurance
29 August 2020 (00:00 - 00:00)
Organised by:
About the speaker
University Heart Centre Freiburg-Bad Krozingen, Bad Krozingen (Germany)
23 More presentations in this session
Doctor L. Moderato (Piacenza, IT)
Associate Professor A. Banerjee (London, GB)
Miss C. Ferreira (Coimbra, PT)
Access the full session
The Event
ESC Congress 2020
29 August - 1 September 2020
